<?xml version="1.0" encoding="UTF-8"?>
<p id="Par114">A minimum of 3 patients will be accrued. Assuming a worst case scenario where the maximum number of patients accrued cannot be planned and require additional enrolment, a maximum of 48 patients will be accrued to this Phase I dose escalation study (12 per dose level).</p>
